We are live on ! Find out more
SBC

SBC Medical Group
SBC

4 hedge funds and large institutions have $288K invested in SBC Medical Group in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

66% more capital invested

Capital invested by funds: $173K → $288K (+$115K)

0.06% more ownership

Funds ownership: 0.03% → 0.09% (+0.06%)

0% more funds holding

Funds holding: 4 → 4 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$171K
2
Marshall Wace
Marshall Wace
United Kingdom
+$52.1K
3
SS
SBI Securities
Japan
+$45.8K

Top Sellers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
-$117
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$196K +$171K +37,604 +158%
SS
2
SBI Securities
Japan
$52.8K +$45.8K +10,092 +156%
Marshall Wace
3
Marshall Wace
United Kingdom
$36.6K +$52.1K +11,485 New
Morgan Stanley
4
Morgan Stanley
New York
$2.87K – – –
TRCT
5
Tower Research Capital (TRC)
New York
– -$117 -21 Closed

SBC Hedge Fund Activity: Q1 2025 in Review

4 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in SBC Medical Group (SBC) for Q1 2025, worth a combined $288K — up 66% from $173K a quarter earlier.

Fund positioning in SBC was balanced in Q1 2025: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, adding an estimated $171K. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $117 sold.

  • 4 institutional investors held SBC Medical Group (SBC) as of Q1 2025, unchanged from Q4 2024.
  • Funds reported $288K of SBC Medical Group stock for Q1 2025, up 66% quarter-over-quarter.
  • 1 fund opened new SBC Medical Group positions in Q1 2025 and 1 closed out, a net change of 0 holders.
  • The largest SBC Medical Group buyer in Q1 2025 was UBS Group, an estimated $171K added.
  • The largest SBC Medical Group seller in Q1 2025 was Tower Research Capital (TRC), an estimated $117 sold.

Based on aggregated 13F filings for Q1 2025.